The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566
Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure
Melnikov, V. Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M. S., Dinarello, C. A., Schrier, R. W., & Edelstein, C. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12089 · Cited by 476
Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4618 · Cited by 301
IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor
Fantuzzi, G., Reed, D. A., & Dinarello, C. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7501 · Cited by 189
In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
Rothe, H., Jenkins, N. A., Copeland, N. G., & Kolb, H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119181 · Cited by 159
Katsuki, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.859 · Cited by 129
Desfaits, A.-C., Serri, O., & Renier, G. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.487 · Cited by 123
Cited by
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“IL-18 plasma levels are increased in obese people and in individuals with T2D (Moriwaki et al., 2003; Evans et al., 2007) while being restored in subjects who have lost weight following bariatric surgery (Schernthaner et al., 2006).”
BackgroundInflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
Fain, J. N. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74018-3 · Cited by 679
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Inflammation in Diabetic Nephropathy
Lim, A. K. H., & Tesch, G. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/146154 · Cited by 437
Kohut, M. L., McCann, D. A., Russell, D. W., Konopka, D. N., Cunnick, J. E., Franke, W. D., Castillo, M. C., Reighard, A. E., & Vanderah, E. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.12.002 · Cited by 436
“IL-18 is a pleiotropic inXammatory cytokine that is elevated in the serum of Type II diabetics and is a predictor of cardiovascular death and future coronary heart disease (Blankenberg et al., 2002, 2003; Moriwaki et al., 2003).”
BackgroundDeficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
Netea, M. G., Joosten, L. A. B., Lewis, E., Jensen, D. R., Voshol, P. J., Kullberg, B. J., Tack, C. J., van Krieken, H., Kim, S.-H., Stalenhoef, A. F., et al. (2006) · Nature Medicine · doi:10.1038/nm1415 · Cited by 424
Monocytes from type 2 diabetic patients have a pro-inflammatory profile
Giulietti, A., van Etten, E., Overbergh, L., Stoffels, K., Bouillon, R., & Mathieu, C. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.007 · Cited by 400
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
Satchell, S. C., & Tooke, J. E. (2008) · Diabetologia · doi:10.1007/s00125-008-0961-8 · Cited by 361
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Rayego-Mateos, S., Morgado-Pascual, J. L., Opazo-Ríos, L., Guerrero-Hue, M., García-Caballero, C., Vázquez-Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 334
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., & Liew, F. Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.218867 · Cited by 324
Bonnet, F., & Scheen, A. J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.005 · Cited by 308
Pichler, R., Afkarian, M., Dieter, B. P., & Tuttle, K. R. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00314.2016 · Cited by 295
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 292
Inflammatory Cytokines in Diabetic Nephropathy
Donate-Correa, J., Martín-Núñez, E., Muros-de-Fuentes, M., Mora-Fernández, C., & Navarro-González, J. F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/948417 · Cited by 277
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
Bhattacharjee, N., Barma, S., Konwar, N., Dewanjee, S., & Manna, P. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.022 · Cited by 271
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Jung, C.-Y., & Yoo, T.-H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0329 · Cited by 262
Ballak, D. B., Stienstra, R., Tack, C. J., Dinarello, C. A., & van Diepen, J. A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.005 · Cited by 255
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958790 · Cited by 164
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
Donate-Correa, J., Ferri, C. M., Sánchez-Quintana, F., Pérez-Castro, A., González-Luis, A., Martín-Núñez, E., Mora-Fernández, C., & Navarro-González, J. F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.628289 · Cited by 140
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., & Yamamoto, T. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0007-6 · Cited by 110
Self-citationMonocytes and macrophages as protagonists in vascular complications of diabetes
Kanter, J. E., Hsu, C.-C., & Bornfeldt, K. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00010 · Cited by 76
Yamanishi, K., Maeda, S., Kuwahara-Otani, S., Hashimoto, T., Ikubo, K., Mukai, K., Nakasho, K., Gamachi, N., El-Darawish, Y., Li, W., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1684-3 · Cited by 15
Metadata
- Authors
- Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 52
- Issue
- 5
- Pages
- 605-608
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2049735903
- Cited by
- 270
- References
- 20
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.